Esketamine is associated with a 7-point reduction in symptoms of treatment-resistant depression at week 1, with nearly 50% of patients responding by week 4, in new research.

An investigative inhaled formulation of the psychedelic mebufotenin is linked to significant improvements in depression ...

Findings should be interpreted with caution, given the lack of placebo effect, expert says ...

For those with treatment-resistant depression, traditional methods often fall short. Learn about TMS, a non-invasive option.

Study of 2,197 patients with resistant depression finds 95 percent improved once parasympathetic and sympathetic ...

Chronic tinnitus is independently associated with depression and anxiety symptoms, according to a study published online in Neuropsychiatric Disease and Treatment. Enes Sırma, from University of ...

Consider a house with the water main half shut. The faucets sputter. The toilet runs all night. The garden wilts. You could call a plumber for the faucet, a landscaper for the garden, a different ...

One woman spent years battling symptoms she couldn’t name—until a diagnosis and treatment finally brought clarity and renewed ...

Patients with treatment-resistant depression who engaged in a single day of treatment with inhaled mebufotenin reported ...

A Long Relaxing Soothing Music Video to Calm Down your Anxiety and Prevent Anxiety or Panic Attacks. Learn to Free the Mind playing this Natural Stress Reliever with Calming and Peaceful Background ...

Why does ketamine wear off so fast? New research identifies the NOX-1 enzyme as a key target to prolong ketamine’s antidepressant effects for treatment-resistant depression.